Regulation of nuclear factor-κ B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E. by Ivanov, Vladimir N. et al.
Regulation of Nuclear Factor-rcB and Activator Protein-1 
Activities After Stimulation of T Cells Via 
Glycosylphosphatidylinositol-Anchored Ly-GA/E’ 
Vladimir Ivanov,  Tony J. Fleming,2  and Thomas R. Malek3 
Department of Microbiology and  Immunology,  University of Miami School of Medicine,  Miami, FL 33101 
Cross-linking of glycosylphosphatidylinositol-anchored proteins, including mouse Ly-bNE, leads to IL-2 secretion 
and T cell activation, whereas engagement of  Ly-6NE  uniquely  inhibits IL-2 production  induced  via TCR. How- 
ever, little is  known  concerning the molecular  mechanism by  which glycosylphosphatidylinositol-anchored pro- 
teins regulate IL-2 expression. In this study, we have examined the ability of an anti-Ly-6NE mAb to regulate 
transcription factors controlling IL-2 expression. Stimulation of EL4J(Ly-6E).A4 cells wi th  ant i -CD~E or anti-Ly6NE 
mAbs induced nuclear factor (NF)-KB p65-p50 (RelNp50) and AP-1 (Fos/Jun) binding activities and increased 
nuclear factor of activated T cells (NF-AT) activity, whereas octamer-binding factor and NF-Y levels were stable. 
Cyclic  AMP response element binding  protein and T  cell-specific factor-I (a)  activities  were selectively enhanced 
by  anti-CD3~,  but  not  by anti-LyGNE, which suggests that signaling via the TCR and Ly-6 were not identical. 
Costimulation  of these cells with  both mAbs produced substantially reduced levels of AP-1, NF-AT, and, espe- 
cially, NF-KB p65-p50 whereas cyclic AMP response element binding  protein and T cell-specific factor-1 (a)  were 
induced to a level seen after stimulation by anti-CD3c The inducibility of the IL-2 enhancer in vivo and the 
contribution  of  individual transcription factors for this induction were assessed with use of reporter chloramphen- 
icol acetyltransferase constructs containing the IL-2 enhancer or oligomerized  binding sites for transcription fac- 
tors. These experiments also demonstrated a key role for NF-KB and AP-1 in the  transcriptional  regulation of the 
IL-2 gene by TCR- and  Ly6NE-mediated  signaling. By using the 284.1 1  T cell  hybridoma and a  mutated variant, 
we revealed a crucial  role for the (-chain in Ly6NE-mediated activation  of NF-KB. The Journal oilrnrnunology, 
1994, 153:  2394. 
T cell activation is accompanied by the coordinated transcription of many genes, including the lym- phokines IL-2, IL-4, IFN-y, and their respective 
receptors (1, 2). The structure of the regulatory region of 
the IL-2 gene has been well characterized (3-5). Tran- 
scription factors that interact with cognate motifs in this 
region are AP-14 (6), NF-KB (3,7), NF-AT (3), OCT-OAP 
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@-lo), and NF-KB/Rel-like factors, which serve as com- 
ponents of the CD28 response element-binding complex 
Because the affinity  of TCR  binding to the MHC peptide 
is low, many co-receptors, including CD4 and CD8, are 
thought to function to increase and stabilize cell-cell interac- 
tions and to enhance the development of intracellular signals 
(13). In addition to  receptor molecules having typical trans- 
membrane and intracellular domains, glycosylphosphatidyl- 
inositol (GP1)-anchored proteins, such as human CD59, 
mouse Ly-6,  and Thy-1, have been implicated in the regula- 
tion of T cell activation (14). mAb binding to these proteins 
readily  affects T cell activity, including IL-2 expression and T 
cell proliferation.  Recent studies have shown that signal 
transduction for these proteins is dependent on their GPI an- 
chor (15, 16) and the expression of the (“chain of the TCR 
complex (17, 18). Src-family and other unidentified  protein 
tyrosine kinases have been demonstrated in Ly-6 and Thy-1 
immunoprecipitates, which suggests that these proteins may 
be linked to the interior of the cell by another transmembrane 
protein (19). Ly-6 proteins may have a broader role in the 
regulation of T cell activation, thus, resulting not only in 
(11, 12). 
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Table I. Oligonucleotide probes with  binding sites for transcription factors 
Sequences" Sites  Factors  Enhancers 
5' 3' 
agctTGGGGACTTTCCAGCCG (KB)  NF-KB HIV 
agctTGGGGATTCCCCATCTG (KB)  NF-KB M H C l  
agcTGAGGGATTTCACCTCG ( K B )  NF-KB  IL-2 
agcTGATGAGTCAGCCG VRE) AP-1 collagenase 
gatccAATTCCAGAGAGTCATCAGA (IL-2, -1 50) AP-1  IL-2 
agctCCATGACGTCATGG (CRE) CREB TCR-a 
AAAGAGGAAAATTTGTTTCATACAGAA (ATl) '  N F-AT IL-2 
GAAAATATGTGTAATATGTAAAACATTTTG (IL-2A)'  OCT IL-2 
AAAAAAGAACAAAGGGCCTAGATT (CD4 = 2) TCFl (a) CD4 
GTCTGAZLACATTTTTCTG-TTAAAAGT 
TGAGTGCT (Y-BOX) N F-Y MHCII(Ea) 
' Onlv one strand of a double-stranded oliaonucleotide is shown. Known binding  sites of transcription  factors are underlined. 
"(NF:AT),- and non-canonical AP1-binding  sites are underlined. 
' Non-canonical Oct-binding site is underlined. 
up-regulation of cytokine production, but also in down-reg- 
dation of IL-2 secretion after simultaneous engagement of 
Ly-6A/E and the TCR complex in T cell lines and  normal T 
lymphocytes (20). 
Currently, little is known about the molecular mecha- 
nism by which GPI-anchored proteins regulate IL-2 ex- 
pression. In this  study, we have examined  the ability of an 
anti-Ly-6W mAb to induce  transcription  factors  control- 
ling 1L-2 expression, namely NF-KB, AP-1, NF-AT, and 
OCT, and several  other  factors important for regulation of 
gene expression in T cells, such as CREB, TCF-l(a)/ 
LEFl (21), and the ubiquitous CCAAT binding factor, 
NF-Y (22). We have revealed differential regulation of 
transcription factor  binding  activities by using anti-CD~E 
and anti-Ly-6NE mAb  stimulation and have established  a 
key role for NF-KB and AP-1 transcription  factors in pos- 
itive or negative  signaling  via Ly-6 proteins. 
Materials and Methods 
Cell lines  and hybridomas 
EL4J(Ly-6E).A4 cells were derived by transfection of the EL4.J thymoma 
cells with the expression plasmid vector PEG-2, which contained exons 
2, 3, and 4 of Ly-6AIE gene (18). 2B4.11 is a T cell hybridoma specific 
for pigeon cytochrome c and I-Ek (23). MA5.8 is a mutant of 2B4.11 
characterized by the absence of TCR 5- and 4-chains expression and by 
low levels of surface TCR. 2A7.37 is a  subclone of the 2A7 cell line, 
which was made by transfecting MA5.8 with full-length mouse ("chain 
cDNA (24). The  B cell lymphoma A20 cells (25) were treated with mi- 
tomycin C  (25  pgiml;  Sigma,  St. Louis, MO) and used as accessory cells 
when indicated. 
A bs 
The following mAbs were used in this study to stimulate T cells and have 
been characterized previously: anti-Ly-6-, to a nonpolymorphic Ly- 
6A.2/E.1 (D7) (26); ant i -CD~E (145-2C11) (27); and anti-Thy-1 ((37) 
(28).  A polyclonal rabbit antiserum to the pS0 subunit of NF-KB (29) was 
kindly provided by Drs. K. Bruhn and M. .I. Lenardo (National Institutes 
of Health). Polyclonal rabbit antiserum 567 to an N-terminal peptide of 
the p65 subunit of NF-KB and polyclonal rabbit antiserum 561 to a C- 
terminal peptide of p65 (30) were kindly provided by Dr. W. Greene 
(Gladstone Institute). Polyclonal antiserum 1226 to a C-terminal peptide 
of p65 subunit of NF-KB and polyclonal antiserum 265 to a C-terminal 
peptide of c-Re1 (31) were kindly provided by Dr. N. Rice (National 
Institutes of Health). Rabbit antisera to full-length c-Fos (32) and to 
vJun  (33) were kindly provided by Drs. T. Curran (Roche Institute 
of Molecular Biology) and H. Rahmsdorf, (University of Karlsruhe), 
respectively. 
Culture conditions 
Culture conditions to induce IL-2 secretion have been described previ- 
ously (18, 20). To prepare nuclear extracts, T cells (1 X 10' cells/ml) 
were cultured in 100-mm tissue plates, which contained 15 ml  of media 
(20) with anti-CD3c (10% hybridoma supernatant), anti-Thy-1 (10% hy- 
bridoma supernatant), or ant i -Ly-6m (1500 ascites fluid), for 1 to 20 h 
in either the presence or absence of A20 cells (2 X lo5 cells/ml) as 
indicated. 
Oligonucleotides and electrophoretic mobility shift 
assay (EMSA) 
Sequences of double-stranded oligonucleotides used in this study are 
shown in Table I. These oligonucleotides were end-labeled with 
[y3'P]ATP using T4 polynucleotide kinase. Nuclear extracts were pre- 
pared from 10 to 15 X lo6 T cells, as described by Schreiber et al. (34). 
Buffers for the extraction of nuclear proteins contained the protease in- 
hibitors PMSF (0.5 pM) and leupeptin, aprotinin, pepstatin, chymostatin, 
and antipain (5 pg/ml each; Sigma). Proteins were quantified according 
to the method of Bradford (35). Binding reactions for all labeled probes 
were conducted by incubating the end-labeled DNA (50,000 cpm) with 5 
p g  of nuclear proteins and 2 p g  of  poly(d1-dC), as described previously 
(36. 37), except that quantities of poly(d1-dC), 1 pgiassay and 400 ngi 
assay, respectively, were used for the NF-AT and the NF-KB(IL-~) 
probes. For competition experiments, a SO- to 200-fold molar excess of 
unlabeled oligonucleotide was added to the reaction mixture before the 
labeled oligonucleotide probe. To identify transcription factors, nuclear 
extracts were preincubated with 1 pl of specific antiserum for  15 min  at 
20°C before the addition of the labeled oligonucleotide probes. There- 
after, labeled probes were added and the incubation was continued for an 
additional 30 min, followed by EMSA. Gels were dried and exposed 
overnight at  -80°C with intensifying screens. 
Transfection  and CAT  assay 
T  cells that were growing in log phase were transfected by the DEAE- 
dextran method, as described previously (38). Reporter CAT constructs 
are shown in Table 11. Reference plasmid pRSVPgal was used as  a con- 
trol for transfection efficiency. For each transfection experiment, 5 X 10' 
cells were treated  with SO pg  of  reporter  plasmid DNA, 10 pg  pRSVpgal, 
and 250 pgiml DEAE-dextran (Sigma).  Twenty hours after transfection each 
cell culture was split into five 100-mm tissue plates and stimulated with 
PMA or mAbs as described above. After an additional 20 h of culture, 
transfected cells were harvested  and  used  to isolate total cell extracts. Protein 
concentrations of cell extracts were normalized on the  basis  of P-galactosi- 
dase activity of transfected nonstimulated cells to correct for transfection 
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Table II. Reporter CAT plasmids 
Plasmid Regulatory  Region  Binding  Site  Reference 
plLCAT2/1+  -293/-7 mouse IL-2 OCT, AP-1, NF-KB, (4) 
with TK promoter 
5 X TRE 5 X (-73/-65 collagenase) 5 X AP-1 (39) 
with  TATAAAA box 
5 X TCE, 5 X (-215/-191  mouse IL-2) 5 X NF-KB  (4) 
pILCAT2/1 -M(3X) 
with  minimal IL-2 promoter 
3 X (-293/-200 mouse IL-2) 3 X (NF-AT, OCT, and NF-KB) (40) 
with minimal IL-2 promoter 
4 X Pub, 4 X (-294/-264 mouse IL-2) 4 X NF-AT  (40) 
with TK-promoter 
-121/+232  HIV LTR 2 X NF-KB, 3 X SPl (38) 
and NF-AT 
-121 HIV-CAT 
-76  HIV-CAT  -76/+232 HIV LTR 3 x SP1 (38) 
efficiency. Equal quantities of total protein extract (usually between 100 and tion of NF-KB and AP-1 was specific, inasmuch as the 
200 pg) for control and stimulated cells of each transfection experiment 
were  assayed for CAT activity. Quantitation of CAT assays was performed levels of the transcription factor NF-Y binding activity 
by liquid scintillation counting of the appropriate area from chromatography were  stable after mAb stimulation of EL4.J (Fig. lA, lunes 
plates. Relative CAT activity (or fold of induction) was determined as a ratio 13 through 15). Inducible NF-KB activity was readily de- 
of the percentage  of acetylated chloramphenicol for activated cells to that  for 
control nonstimulated cells. tectable in EL4J cells after 30 to 60 min of PMA treat- 
ment, whereas anti-CD3c stimulation induced detectable 
Results 
Induction of transcription factor  binding activities in 
EL4J(Ly-6E).A4 cells by anti-CD3c and anti-Ly-6NE 
mAb stimulation 
Stimulation of various T cell lines by anti-CD3c has been 
shown to induce binding activity of nuclear transcription 
factors NF-KB and AP-1, which regulate IL-2 transcription 
(41, 42, 6). To begin to determine the molecular basis by 
which T cell activation and IL-2 production is regulated 
via Ly6NE signaling, we used EMSA to detect transcrip- 
tion factor binding activities in nuclear extracts that were 
prepared from untransfected or Ly-6E-transfected ELAJ 
cells after stimulation with a n t i - L y - 6 u  or anti-CD~E 
mAbs. As expected, anti-CD3c, but not anti-Ly-6A/E, in- 
duced NF-KB (Fig. lA, lunes 1 through 3 and 5 through 7) 
and AP-1 (A, lanes 9 through 11) nuclear transcription 
factor binding activities 6  h after stimulation of untrans- 
fected EL4J thymoma cells, which are Ly-6A/E negative 
(18). Similar results were obtained with use of two differ- 
ent NF-KB probes, one for the KB motif from the HIV 
enhancer (Fig. 1A, lunes I through 3),  and another for the 
palindromic KB motif from the MHC  class  I enhancer (A, 
lunes 5 through 7). The induction of NF-KB was most 
notable in the upper complex I, whereas complex I1 was 
relatively stable. Previously, inducible complex I has been 
identified in various cell lines as  a heterodimeric p65p50 
NF-KB DNA-binding complex and lower complex I1 has 
been identified as  a homodimeric p50-p50 NF-KB DNA- 
binding complex (43). The palindromic NF-KB(MHC I) 
probe binds with high affinity to the p50-p50 homodimer, 
as well as to the p6S-p50 heterodimer, whereas NF- 
KB(HIV) probe preferentially binds to the p65-pS0 het- 
erodimer (44). Our EMSAs performed with the two 
NF-KB probes are consistent with  this finding. The induc- 
NF-KB only after 2 h. This activity became maximal after 
6 to 8 h of stimulation (data not shown). 
Similarly, EMSAs  were performed by using nuclear ex- 
tracts from EL4J cells transfected with the Ly-6.1  expres- 
sion vector. The resulting EL4J(Ly-6E).A4 clone  x- 
pressed relatively high levels of Ly-6E and secreted high 
levels of IL-2 after stimulation with anti-CD~E or anti-Ly- 
6A/E. For these cells, anti-LydA/E and anti-CD3c in- 
duced NF-KB complex I (Fig. l B ,  lanes I through 3 )  and 
AP-1 binding activities (C, lunes 1 through 3 )  6 h after 
stimulation, although the level of induction of these activ- 
ities by anti-Ly-6NE  was lower. In contrast, the level of 
NF-Y was relatively constant (Fig. l B ,  lunes 6 through 8). 
PMA, an inducer of NF-KB and AP-1 binding activities 
and of high levels of IL-2 secretion in ELA cells (45, 46), 
also dramatically increased NF-KB complex I (Fig.lB, 
lune 5 )  and AP-1 binding activities (C, lune 5).  Further- 
more, in the induction of AP-1 by anti-Ly-6NE or anti- 
CD3q increased binding activity was noted with use of the 
canonical AP-1 probe, the TRE motif from the collagenase 
promoter (Fig. lC, lanes I through 3), or a second AP-1 
probe, the proximal noncanonical AP-1 binding motif 
from the IL-2 promoter at position - 150 bp (C, lunes 6 
through I O ) .  Because this latter probe detected some ad- 
ditional nonspecific activities, the position of the specific 
complex is indicated by an arrow. 
PMA treatment of EL4J(Ly-6E).A4 cells induced 
three specific NF-AT DNA-binding complexes, desig- 
nated b l ,  b2, and  b3 (Fig. 1D, lune 5) .  Anti-CD3c pri- 
marily induced b l  and b2 (Fig. lD, lane 2), whereas 
anti-Ly-6A/E minimally  increased  the binding  activities 
represented in these  two  bands 6 h after treatment ( D ,  
lune 3).  These  bands represented  a specific NF-AT 
complex  on  the  basis of competition with unlabeled  oli- 
gonucleotides,  inhibition of induction of these bands by 
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FIGURE 1. Induction of nuclear transcription factor binding activities in stimulated EL4J or EL4J(Ly-6E).A4  cells. EMSAs were 
performed with nuclear extract proteins from EL4J cells ( A )  and EL4J(Ly-6E).A4 cells ( B  through F)  that  either  were not treated 
or were stimulated with mAbs and PMA (10 ng/ml), as indicated above each lane, for 6 h ( A  through E )  or 20 h (F). The 
following labeled oligonucleotides were used for DNA-binding reactions: NF-KB(HIV) (A, lanes 7 through 4),  NF-KB(MHC I) 
(A, lanes 5 through 8),  AP-1 (TRE) (A, lanes 9 through 72), and NF-Y probes (A, lanes 73 through 76); NF-KB(HIV) (B, lanes 7 
through 5)  and NF-Y probes (B,  lanes 6 through 70); AP-l(TRE) (C, lanes 7 through 5)  and AP-1(-150,  IL-2)  probes (C, lanes 
6 through 70); NF-AT and NF-Y  probes (D); OCT probe (IL-2A motif from IL-2 promoter), CREB probe (CRE motif from TCR-a 
enhancer), and TCF-1 (a) probe (CD4 = 2 oligonucleotide sequence from CD4 enhancer) ( E ) ;  NF-KB(HIV), AP-1  (TRE),  NF-AT, 
and NF-Y  probes (panel F). In all panels, F refers to the free-labeled probes. Two main bands of retardation produced by NF-KB 
probes are designated as complex I and complex I I  NF-KB ( A  and €3). Three bands of specific NF-AT binding activity are 
designated as b l  , b2, and b3; ns, nonspecific activity (D). 
treatment o f  cells with cyclosporin A (3), and partial 48) (data not shown). I n  contrast, OCT binding activities 
inhibit ion of complex  formation  by pretreatment o f  (OCTI, OCT2b, and OCT2a) were relatively stable after 
nuclear extracts with antisera to v J u n  and c-Fos (47, anti-CD~E or ant i -Ly-6m stimulation of  EUJ(Ly-6E).A4 
2398 T CELL ACTIVATION VIA Ly-6 A N D  TRANSCRIPTION FACTORS 
FIGURE 2. Induction of transcription 
factor  binding  activities in nuclear  ex- 
tracts of  EL4(Ly-6E).A4 cells  stimulated 
with anti-CD~E and anti-Ly-6NE mAbs 
in the presence of mitomycin-C-treated 
A20 accessory cells. EMSAs were per- 
formed with labeled NF-K(HIV), (lanes 
1 through 4) ,  NF-KB(IL-~) (lanes 5 
through 8), and NF-Y probes (lanes 9 
through 72). The main bands of NF-KB 
activity are indicated as complexes I 
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cells  (Fig. lE,  lanes 1 through 3).  Collectively,  these  exper- 
iments  indicated  that  signaling  via C D ~ E  or Ly-6AiE  up-reg- 
ulated NF-KB,  AP-1, and  NF-AT  binding  activities,  although 
the  induction  by  anti-Ly-6AiE  usually  was  weaker.  TCR-  and 
Ly-6AE-mediated signals did not influence the levels of 
OCT and NF-Y; however, activation of EUJ(Ly-6E).A4 
cells  with anti-CD3~, but  not anti-Ly-6AE, increased  bind- 
ing  activity  of CREB (Fig. lE, lanes 5 through 7) and,  es- 
pecially, TCF-l(a)/LEFl (E,  lanes 9 through I ] ) ,  further 
suggesting  that  specific  signals  emanate  from C D ~ E  and  Ly- 
6AE. 
Down-regulation of transcription factor binding 
activities by costimulation of EL4J(Ly-6E).A4 cells 
with  anti-CD~E and anti-Ly-6NE mAbs 
Although anti-Ly-6NE directly induces IL-2 production, 
past studies have demonstrated that co-incubation of Ly- 
6AE-positive T cells with anti-CD~E and anti-Ly-6A/E 
resulted in substantial inhibition of IL-2 production (18, 
20). To further characterize the basis of this phenomenon, 
EMSAs also were performed with use of nuclear extracts 
prepared  from EL4J(Ly-6E).A4 cells 6 h after co-incuba- 
tion  with anti-CD~E and anti-LydNE. The levels of 
NF-KB complex I (Fig. lB, lane 4) ,  AP-1 (C,  lanes 4 and 
9) ,  and NF-AT complexes bl  and b2 (0, lune 4)  were 
significantly less when compared with cells stimulated 
only  with anti-CD~E. This decrease was specific because 
the levels of NF-KB (Fig. lA, lanes 4 and 8 )  and AP-1 (A, 
lane 12)  after costimulation of untransfected EL4J cells by 
anti-CD~E and anti-LydA/E were comparable to cells 
only stimulated by anti-CD3c Furthermore, costimulation 
of EUJ(Ly-6E).A4  cells by these two  mAbs  did not result 
in reduced binding activity of CREB (Fig. IE, lune 8 )  and 
TCF-l(a) ( E ,  fane 12)  when compared with cells stimu- 
lated solely by anti-CD3c This result is important because 
it indicated that anti-Ly-6NE does not down-regulate all 
signaling through  the TCR complex. Thus, these data sug- 
gest that the capacity of anti-Ly-6NE to inhibit anti- 
CD3einduced 1L-2 production by ELAJ(Ly-6E).A4 cells 
2 3 4 5 6 7 8 9 1 0 1 1 1 2  
is the result of a selective negative effect  on NF-KB, AP-I, 
and  NF-AT binding activities. 
It should be stressed that although the data shown are 
from representative experiments, similar results were seen 
in more than 10 experiments. Furthermore, time-course 
studies revealed maximal levels of NF-KB and AP-1 ac- 
tivities induced by anti-CD~E after 6 h of treatment. When 
nuclear extracts were prepared 20 h after culture initiation 
(Fig. l F ) ,  the level of inducible AP-I activity was already 
reduced after TCR and Ly-6NE stimulation, whereas 
NF-KB and  NF-AT activities reached the maximal  level at 
this  time  then  gradually  declined  during  next  20 h (data  not 
shown). In any case, the inhibition of anti-CD3e-induced 
NF-KB and  NF-AT  by anti-Ly6AE was more  pronounced  20 
h after mAb  treatment,  whereas  down-regulation  of A P - I  ac- 
tivity  was  already  less  pronounced  at  this  time as compared 
with 6 h after  culture  initiation.  (Fig. IF). 
Activation of IL-2 production in T cells by anti-CD~E 
and/or anti-LydAE is  dependent  on  cross-linking of cell  sur- 
face bound  mAbs  by  FcR  on  accessory  cells or by a second 
Ab  specific  for  Ig.  Activation  of  EL4J  cells  does  not  require 
co-incubation with accessory cells because the former ex- 
press  sufficient  FcR  to  cross-link  the  mAbs  (data  not  shown). 
When A20 accessory  cells  were  included in the  culture, sim- 
ilar  regulation of NF-KB activity by anti-CD~E and  anti-Ly- 
6AE was  seen  after 6 h, although  the  level  of  induction  of 
NF-KB complex I ( ~ 6 5 ~ 5 0 )  binding activity by anti-Ly- 
6A/E was  higher  than in the  absence  of  accessory  cells  (Fig. 
2, lanes 1 through 4). There was less marked induction of 
NF-KB activity  when  the NF-KB(IL-~) probe  for  EMSA  was 
used and this may be a result of the lower affinity of this 
probe  to  NF-KB  complex 1( ~ 6 5 ~ 5 0 )  (Fig.  2, lanes 5 through 
8). NF-Y served as an internal standard for these nuclear 
extracts  (Fig. 2, lanes 9 through 12). 
Identification of transcription factor binding activities 
by  using specific Ab pretreatment 
EMSAs in which oligonucleotide competition was used 
confirmed the specificity of the nuclear NF-KB binding 
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activity in EL4 cells (data not shown). For precise identi- 
fication  of inducible and constitutive NF-KB DNA binding 
activities, 6 h after anti-CD~E stimulation, nuclear extracts 
from EL4J(Ly-6E).A4 cells were pretreated with poly- 
clonal Abs to distinct subunits of NF-KB before EMSA. 
As was expected, anti-p50 serum almost completely in- 
hibited  the formation of complexes I and I1 and  produced 
a supershift that  likely corresponded to complex I (Fig. 3A, 
lanes 2 and 7), whereas preimmune serum  did  not specif- 
ically influence NF-KB complexes (Fig. 3A, lanes 3 and 
8). Similar results were seen when extracts from anti-Ly- 
6 N E  activated cells were used (data not shown). Anti- 
p65(C) 561 serum specific for a C-terminal peptide of  p65 
partially inhibited the formation of complex I and pro- 
duced a supershift of this complex that was most  readily 
detected by using  the NF-KB(MHC I)  probe (Fig. 3A, lane 
4 vs lane 9). By using three different antisera to p65 NF- 
KB, the  level of complex I was substantially inhibited for 
nuclear extracts from anti-LydA/E stimulated cells (Fig. 
3B, lanes 7 through 11); we also noted inhibition and/or 
supershifts for anti-CD3e (B, lanes 1 through 5 )  or PMA- 
activated cells (B, lanes 13 through 17). In contrast, anti- 
c-Re1  did  not inhibit formation of NF-KB complexes I and 
I1 (Fig. 3, A, lanes 5 and 10; and B, lanes 6,  12, and 18). 
Thus, these data indicated that  PMA, anti-CD3~, and anti- 
Ly-6NE all  induced canonical p65-p50 NF-KB repre- 
sented in complex I, whereas complex I1 was homodimer 
p50-p50. However, the relatively high  level of resting 
NF-KB activity after anti-p65 treatment of extracts, espe- 
cially those from anti-CD3e or PMA-activated cells, 
raises the possibility that other NF-KB/Rel-related proteins 
might comprise complex I. 
Competition experiments with  e canonical AP- 
l(TRE) probe or CREB probe confirmed the specificity of 
FIGURE 3. Identification of NF-KB transcription factor 
DNA-binding activities in EL4J(Ly-6E).A4 cells. EMSAs were 
performed with nuclear extracts of cells stimulated by anti- 
CD3e (panel A),  or PMA, anti-CD3e, or anti-Ly-6NE 6 h after 
culture initiation (panel B) .  Nuclear extracts were preincu- 
bated with Abs to different  NF-KB/Rel-related proteins for  15 
min before  the addition of the following labeled oligonucle- 
otides: NF-KB(HIV) (A,  lanes 7 through 5; B )  and  NF- 
KB(MHC I )  probes (A, lanes 6 through 70). The following Abs 
were used: polyclonal rabbit antiserum to p50 subunit of 
NF-KB (anti-p50) (A, lanes 2 and 7);  polyclonal rabbit anti- 
serum 561 to a C-terminal peptide of p65 (anti-p65C) (A, 
lanes 4 and 9; B, lanes 4, 10, and 76); polyclonal rabbit 
antiserum 1226 to a C-terminal peptide of p65 (anti-p65*) (B,  
lanes 5, I I ,  and 17); polyclonal rabbit antiserum 567 to a 
N-terminal peptide of p65 (anti-p65N) (B, lanes 3, 9, and 15); 
polyclonal rabbit antiserum 265 to a C-terminal peptide of 
c-Re1 (anti-c-Rel) (A, lanes 5 and 10; B, lanes 6, 12,  and 18); 
and preimmune serum (A ,  lanes 3 and 8; 6, lanes 2, 8, and 
14). Control extracts were not treated with Abs (A,  lanes 7 
and 6;  6, lanes I ,  7, and 13). 
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FIGURE 4. Identification of AP-1 and 
CREB transcription  factor binding activ- 
ities in nuclear  extracts of EL4J(Ly- 
6E).A4 cells. EMSAs were performed 
under  standard conditions with the 
indicated  l beled oligonucleotide 
probes,  except  that  nuclear  extracts 
were  preincubated with a 100- or 200- 
fold molar excess of the  indicated un- 
labeled oligonucleotides as competi- 
tors  (Comp.) (A, lanes 2 through 6 and 
8through 7 7; B, lanes9and 70)orwith 
polyclonal rabbit  antiserum to v-Jun 
(anti-v-Jun) (B, lanes 2 and 7), poly- 
clonal rabbit  antiserum to c-Fos (anti-c- 
Fos) (B, lanes 3 and 8), and  preimmune 
serum (B, lanes 4 and 6) .  Control ex- 
tracts were not treated by competitors 
or  Abs (A, lanes 7 and 7; B, lanes 7 and 
5) .  Nuclear extracts  were  isolated from 
cells  stimulated  for 6 h with anti-CD3c 
( A )  and (B, lanes 7 through 41, or  anti- 
Ly -6M (B, lanes 5 through 70). 
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interaction of these labeled probes with transcription fac- 
tors (Fig. 4A). The AP-1 transcription factor is comprised 
of different combinations of  Jun  and  Fos  protein subunits 
(49). Treatment of nuclear extracts from anti-CD3estim- 
ulated EUJ(Ly-6E).A4 cells with  broadly specific antisera 
to vJun and c-Fos, but not with preimmune serum, sub- 
stantially inhibited formation of the AP-1-binding com- 
plexes (Fig. 4B, lunes I through 4). These antisera did  not 
affect  he detection of the CREB complex by EMSA, 
which suggests that CREB was a different transcription 
factor (data not shown). As the inhibition was complete 
with anti-v-Jun, but only partial  with anti-c-Fos, these data 
suggest that  the AP-1-binding complex seems to  be a mix- 
ture of Jun-Jun homodimers and Jun-Fos heterodimers. 
The broad specificity of these antisera do not permit a 
more precise identification of these subunits. Similar re- 
sults were obtained after analysis of nuclear extracts from 
#- CREB 
i k  
I 
32 P-flPt-Drobe. ant i -Lu-BE 
+ flP1 
3 4  5 6 7 8 9 1 0  
anti-Ly-6AE-stimulated EUJ(Ly-6E).A4 cells, although, 
in this case, anti-c-Fos only slightly inhibited the forma- 
tion of specific complex (Fig. 4B, /ones 5 through IO). 
Differential  regulation of transcription factor binding 
activities in EL4(Ly-GNE).A4 cells by anti-Thy-1 and 
anti-Ly-6NE rnAbs 
Cross-linking of GPI-anchored Thy-1 leads to secretion of 
IL-2, but unlike anti-Ly-6A/E, does not inhibit anti-CD3e 
induced IL-2 production (20, 28). Therefore, the ability of 
anti-Thy-I to affect the binding activity of several tran- 
scription factors was examined for EL4J(Ly-6E).A4 cells. 
An EMSA of nuclear extracts demonstrated that anti- 
Thy-1 did not induce NF-KB complex I (Fig. 5, lunes I 
through 3) ,  but  did increase the binding activity of NF-AT 
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FIGURE 5. Comparison of effects of anti-Thy-1,  anti-Ly- 
6NE, and anti-CD3e on the induction of nuclear  transcrip- 
tion  factor  activities in EL4J(Ly-6E).A4 cells. Cells  were  stim- 
ulated for 6 h with mAbs, as indicated above the lanes. 
EMSAs were performed with labeled NF-K (HIV) (lanes 7 
through 41, NF-AT (lanes 5 through 8), and NF-Y probes 
(lanes 9 through 72). 
to a level almost comparable with that induced by anti- 
C D ~ E  (lanes 5 through 7). These effects were specific as 
judged by the binding activity of NF-Y (Fig. 5, lunes 9 
through 12). Anti-Thy-1 also slightly induced AP-1 (data 
not shown). Furthermore, anti-Thy-1 did not inhibit anti- 
CD3e-induced binding activity of NF-KB (Fig. 5, lane 4 )  
and  minimally decreased anti-CD3einduced NF-AT (lane 
8). Thus, the regulation of several transcription factors, 
which are important for expression of 1L-2 gene, is dif- 
ferent after activation by anti-Thy-1 and anti-Ly-6A/E. 
peated 3 or 4 times.  Data  from  representative  experiments  are 
shown  on  Figure  6.  Plasmid  pILCAT2/1+  contained  the 
-293/-7-bp regulatory  region  of  the  mouse  IL-2  gene  with 
binding sites for Om, NF-KB, AP-I, and NF-AT. Cells 
transfected with this construct (Fig. 6A) showed strong in- 
duction of CAT  expression  after anti-CD~E or PMA stimu- 
lation, whereas anti-Ly6AE induced a moderate level of 
CAT activity. Costimulation of transfected cells with both 
mAbs strongly inhibited CAT activity compared with that 
induced by anti-CD~E alone  (Fig. 6A, lanes 1 through 4) .  The 
enhancerless  vector with the TK promoter, pBLCAT2, and 
the CAT construct  with a minimal  IL-2  promoter  were  not 
inducible  (data  not  shown). 
To assess the roles of individual transcription factors for 
TCR- or Ly-6A/E-dependent signaling, we  used  different 
plasmid constructs with  oligomerized  binding  sites  for  tran- 
scription factors as artificial enhancers. Plasmid 5x TRE- 
CAT,  which  contained  five AP-1 sites  from  the  collagenase 
gene (Fig. 6A, lanes 6 through IO), and plasmid SxTCE,, 
which  contained  five  NF-KB  binding  sites  from  the  IL-2 en- 
hancer (C,  lanes 6 through IO), were  induced  with  mAbs or 
PMA in a manner that was  analogous to that  detected  with 
plLCAT2/1+, although  the  magnitude  of this response  was 
lower. Furthermore, costimulation of cells with both mAbs 
also  inhibited  NF-KB-  and  AP-1-dependent CAT activity. 
To determine  whether  NF-AT  contributed to the  induction 
of  mouse IL-2  transcription in vivo,  we  transfected EUJ(Ly- 
6E).A4 cells with the 4xPub,-CAT construct, which con- 
tained four  repeats  of  the  distal  NF-AT  binding  site  from  the 
mouse IL-2 enhancer. Interestingly, this construct was in- 
duced  substantially by  PMA or PMA  and  ionomycin, 
whereas it was  only  induced  slightly by anti-CD~E and was 
not induced by anti-Ly-6AE (Fig. 6B, lanes 6 through 10). 
The more  complicated  pILCAT-2/1-M(3x)  construct,  which 
contained a trimer of the  murine  NF-AT  site, OCT site, and 
most  of  the NF-KB site (-293 to -200 bp), was character- 
ized  by a relatively  high  induction  of CAT after  treatment by 
anti-CD3e and a low  induction  by anti-LydAE. Thus, 
NF-AT  seems to contribute to the  induction of CAT activity 
by anti-CD~E only in the  context of OCT and NF-KB, 
whereas a role for NF-AT was not obviously detected for 
stimulation by anti-LydA/E. 
We also used a second probe for NF-KB-directed tran- 
scription, the -121 HIV-CAT construct with  two NF-KB 
and three SP-1 sites from the HIV-LTR. The -76 HIV- 
CAT construct with  three SP-1 sites served as a negative 
control (Fig. 60) .  For the -121 HIV-CAT construct, 
Inducibility of the lL-2 enhancer determined by 
CAT assay 
moderate levels of CAT induction, similar to those de- 
tected for the 5x TCE,-CAT, were observed after stimu- 
lation either by anti-CD3e or anti-Ly-6A/E. 
To probe in vivo for transcription transactivator function Taken together, these data demonstrated that TCR- and 
of factors that were induced by mAbs or PMA treatment, LydA/E-mediated regulation of IL-2  transcription in 
ELAJ(Ly-6E).A4 cells were transfected with reporter con- EUJ(Ly-6E).A4 cells  primary is based  on  induction  of 
structs carrying binding sites for different transcription NF-KB and AP-1 transcription  factor  activities  that  induced 
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FIGURE 6. CAT activity directed by IL-2-enhancer CAT  or AP-1- NF-KB- and NF-AT-dependent reporter CAT constructs in 
EL4J(Ly-6E).A4 cells stimulated with mAbs or PMA. Cells were transfected with reporter plasmids pILCAT2/1 + (A, lanes 7 
through 5) ,  5xTRE-CAT (A,  lanes 6 through 70), pILCAT2/1-M(3x) (€3, lanes 7 through 5),4xPub,,-CAT (B, lanes 6 through 701, 
-1 21 HIV-CAT (C, lanes 1 through 5; D, lanes I through 5) ,  -76 HIV-CAT (D, lanes 6 through 701, and 5xTCE,,-CAT (C, lanes 
6 through 70) and were  activated with mAbs or PMA, as indicated below the lanes. One experiment representative of four is  
shown. Average induction levels of CAT activity on the basis of the ratio of the percentage of conversion of  chloramphenicol 
to the acetylated form are shown above the lanes. 
In the  case of stimulation  with  both  mAbs, Ly-6AErnedi- 
ated signals also inhibited anti-CD3c induction of the IL-2 
enhancer  at  the  level  of  these two transcription  factors. 
Role of TCR 5-chain for induction of nuclear p65- 
p50 NF-KB after anti-Ly-6NE  stimulation of 2B4.17 
T cell  hybridoma 
Previous studies have demonstrated that anti-Thy-1- or 
anti-Ly-6A/E-induced IL-2 production in the 2B4.11 T 
cell hybridoma is dependent on expression of the TCR 
5-chain, whereas anti-Ly-6NE-mediated inhibition of an- 
5CD3e-induced IL-2  production seems to  be independent 
of TCR-5 (17, 18). To determine whether anti-Ly-6NE 
similarly regulated transcription factor activities in a cell 
other than  EL4J  and  to assess the  role of TCR-5 as a signal 
transduction  molecule  to  induce  transcription  factors, 
EMSAs  were  performed  with  nuclear  extracts  of  the  2B4.11 
T cell hybridoma, its TCR-[-negative variant, MA 5.8, and 
the TCR-C; retransfectant of MA5.8, 2A7.37. As was seen 
with EUJ(Ly-6E).A4 cells, the addition of anti-CD3c or 
anti-Ly-6AE 6 h after  treatment  substantially  induced  p65- 
p50  NF-KB  binding activity in 2B4.11  cells  (Fig. 7A, lrrws I 
through 3) .  Anti-CD3, but  not anti-Ly"E, induced 
p65-p50  activity in TCR-(-negative  MA5.8.  (Fig. 7A, lanes 5 
through 7); both Abs induced p65-p50 NF-KB in 2A7.37 
cells (A, lanes 9 through If). These  effects  were  specific  as 
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FIGURE 7. A role  for TCR <-chain in NF-KB induction  after anti-LyGA/E T cell  stimulation.  Phenotypes of cells are shown  on 
the top of the  panel.  2B4.11, MA 5.8, and  2A7.37  cells  were  either  untreated (lanes 7, 5, and 9)  or stimulated by different 
combinations of  mAbs in presence of mitomycin-treated  accessory A20 cells,  as  indicated above the lanes  for 6 h. EMSA were 
performed with NF-KB(HIV) (A ) ,  AP-l(TRE) (B ) ,  and NF-Y probes (C). 
judged by reference  NF-Y  activity  (Fig. 7C). Thus,  induction 
of NF-KB and  IL-2  secretion in 2B4.11 cells by anti-Ly-6A.E 
is dependent  on  surface  expression of  TCR-{. However,  anti- 
Ly-6A.E  dramatically  decreased anti-CD3einduced p65-p50 
NF-KB for both  2B4.11  (Fig.  7A, / m e  4 )  and  MA5.8 cells (A, 
/ m e  8), which  indicates  that  this  inhibitory  effect  was  inde- 
pendent of TCR-{ expression.  Somewhat  surprisingly,  cocul- 
tures of anti-Ly-6A.E and anti-CD~E with  2A7.37 cells did 
not inhibit  binding  activity of p65-p50 NF-KB (Fig. 7A, / m e  
12). It is  possible  that  overexpression of the  {-chain in 
2A7.37  cells  enhanced  TCR  signaling  via  the  {-chain  path- 
way,  thus,  overcoming  the  inhibitory  effects of anti-Ly-6A.E 
on TCR signaling. Additional experiments are required to 
confirm this hypothesis. 
In the  presence  of  accessory  cells,  these T cell  hybridomas 
are characterized by relatively high background levels of 
AP-1  binding  activity,  which  increased  after anti-CD~E stim- 
ulation.  Anti-Ly-6A.E  exerted  minimal  capacity to either  di- 
rectly induce AP-I or inhibit anti-CD3einduced levels of 
AP-1 (Fig. 7B). EMSA performed with nuclear extracts of 
these cell lines revealed stable levels of OCTl binding ac- 
tivity  and  trace  levels  of  NF-AT  binding  activity,  which  were 
not induced by mAb treatment (data not shown). Control 
EMSA experiments were performed with nuclear extracts 
from mitomycin-treated A20 (Ly-6A.E-negative) cells and 
compared  with  nuclear  extracts  from  2B4.11.  At  the  standard 
protein concentration used for EMSA, neither NF-KB nor 
AP-1 activities were detected in A20 cells, although these 
activities  were  detected  after  increasing  the  protein  concen- 
tration  10-fold for the  DNA  binding  reactions  (data not 
shown). Thus, it is unlikely that nuclear factors from A20 
cells  contributed  to  the  detection of NF-KB and AP-I from 
nuclear  extracts of 2B4.11  hybridoma  and  its  variants. 
Discussion 
In eukaryotic cells, many different proteins are anchored 
to the external surface of the plasma membrane by co- 
valently attached GPI (50). For mouse T lymphocytes, 
Thy-1 and  Ly-6  proteins  represent  well-characterized  exam- 
ples  whereby  cross-linking of GPI-anchored  proteins  leads  to 
T cell  activation,  especially as measured by IL-2 secretion. 
Little  is  known  about  thc  intracellular  signals  generated  via 
GPI-anchored  proteins. In the  present  study,  we  have  exam- 
ined the induction of nuclear transcription factors (51, 52) 
that  regulate  IL-2  expression  after T cell  stimulation  via  Ly- 
6A/E, Thy-I, and TCR to answer three general questions 
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about the mechanism by which GPI-anchored proteins reg- 
ulate T cell activation. These questions are: 1) What tran- 
scription factors are the targets after signaling via TCR, Ly- 
6AE, and Thy-l? 2) Does activation via Ly-6A/E  and TCR 
proceed through a common signal transduction pathway? 3) 
What is the molecular mechanism by which cross-linking 
Ly-6AE leads to inhibition of IL-2 production induced  via 
the TCR? 
By using Ly-6A/E-transfected EL4J cells as a model, 
we found a specificity in  the pattern of induction of tran- 
scription  factors after stimulation through C D ~ E ,  Ly-6A/E, 
and Thy-1. Anti-CD~E induced high levels of NF-KB, 
AP-1, NF-AT, CREB, and LEF1/-TCF-l(a) binding ac- 
tivities, whereas anti-Ly-6NE induced  moderate  levels of 
NF-KB and AP-1, but only low levels of NF-AT. In con- 
trast, anti-Thy-1 induced moderate levels of NF-AT and 
low levels of AP-1,  but did not activate NF-KB in EL4J 
cells.  Although mAb stimulation via C D ~ E ,  Ly-6A/E, and 
Thy-1 leads to IL-2  secretion,  the  observation that the pat- 
tern of transcription  factors is quite specific for  each mAb 
provides  strong  suggestive  data  for  the specificity of sig- 
nals  emanating  through  each of these protein. 
Consistent with the results from EMSAs, CAT assays de- 
tected TCR- and Ly-6VE-mediated induction of transactiva- 
tor transcription function of NF-KB and AP-1 and a cooper- 
ative activating effect  of these factors on the IL-2 enhancer in 
the context of other factors. Furthermore, co-incubation of 
these cells with both anti-CD~E and anti-Ly-6- resulted in 
substantial inhibition of NF-KB- and AP-1-dependent CAT 
transcription, as well as inhibition of inducibility of the IL-2 
enhancer. In cultures that were parallel to those used for nu- 
clear extract preparation, we confirmed that IL-2 secretion 
was regulated by Ly-6AE-mediated signals and that anti- 
CD3einduced IL-2 production was inhibited by anti-Ly- 
6A/E  (data  not shown). Thus, it seems that  both the activating 
and inhibitory effects of Ly-6AE-mediated signals on IL-2 
expression occur at the level of NF-KB and AP-1 transcrip- 
tion factors. 
In particular, regulation of NF-KB seems to be a key event 
in signaling via Ly6A/E in both the ELAJ(Ly-6E) and the 
2B4.11  model cell systems. In the presence of A20 accessory 
cells, NF-KB p65-p50 was the only transcription factor that 
was dramatically induced in these cell systems by anti- 
Ly6A/E. Inasmuch as AP-1 was also induced in EL4J(Ly- 
6E).A4 cells by anti-Ly-6A/E in cultures lacking accessory 
cells, it is highly likely that AP-1 also may be induced by 
adhesion and/or costimulatory molecular interaction between 
the T cell and accessory cell. By using Ab identification ex- 
periments, we established that anti-CD~E and anti-Ly-6AE 
induced canonical p65-p50 (RelA/pSO) NF-KP binding ac- 
tivity (53). For anti-Ly-6A/E-stimulated cells, this activity 
was almost completely inhibited by several different  anti-p65 
sera in EMSAs, thus, indicating that stimulation via Ly-6AE 
primarily regulates RelA/pSO NF-KB. In contrast, these anti- 
sera only partially inhibited the p65-p50 NF-KB induced  by 
anti-CD~E in EMSAs, thus suggesting that other types of 
NF-KB, e.g., RelB/p50 (54), were also activated via C D ~ E .  
The failure of anti-c-Re1  to  affect NF-KB in EMSAs suggests 
that  c-ReVp50 is not induced in EL4J cells. 
EMSA revealed only a small fraction of nuclear p65- 
p50 NF-KB activity bound in vitro to a specific site in the 
IL-2 enhancer, using the NF-KB(IL-~) probe. However, 
CAT construct with  multiple NF-~B(IL-2)-motif was 
readily transactivated in vivo. It is possible that actual 
binding of NF-KB to the IL-2 enhancer is also regulated by 
protein-protein interactions with other factors. This sce- 
nario has been  shown  for  other  genes that are regulated by 
NF-KB, such as the binding of NF-KB and serum response 
factor in the IL-2Ra enhancer (5.9, NF-KB and HMG I(Y) 
in  the IFN-P enhancer  (56), and NF-KB and C/EBP (57). 
TCR  recognizes  antigenic  peptides bound to MHC  mol- 
ecules on the APCs generating intracellular signals through  at 
least two autonomous transduction modules from either the 
E-  or  (-chain  of the CD3RCR complex (58,59). Analysis of 
Lyd-mediated signal transduction, which was performed 
with use of the 2B4.11 hybridoma and its TCR-(-negative 
mutated variant, indicated  that the ability of anti-Ly6AE to 
inhibit NF-KB p65-p50 binding activity was independent of 
c-chain expression, whereas the direct induction of NF-KB by 
anti-Ly6AE required cell surface TCR (-chain. Furthermore, 
there is a good correlation between the  ability of anti-Ly6A/E 
to regulate NF-KB p65-p50 and the capacity of 2B4.11 cells 
to secrete IL-2. However, this correlation was not  linear, be- 
cause the decrease in the level of anti-CD3e-induced IL-2 
secretion was often much greater than the reduction of 
NF-KB ~ 6 5 ~ 5 0 .  This finding suggests that some critical con- 
centrations of nuclear transcription factors occur for effective 
integrative induction of IL-2 gene transcription. 
Because there is considerable  information about the reg- 
ulation of NF-KB in T cells, we may be able to deduce 
levels at which triggering Ly-6NE molecules affect intra- 
cellular signaling. Activation of NF-KB involves its re- 
lease as a p65-p50 heterodimer from a complex  with  cy- 
toplasmic inhibitor, IKB, and the  subsequent translocation 
of this active form into the nucleus (60). It is likely that 
IKB is  inactivated by phosphorylation,  resulting in the re- 
lease of NF-KB (61, 62). The protein kinase that inacti- 
vates IKB is  unknown, but such a kinase must be linked to 
the signaling cascades. One candidate kinase is Raf-1, 
which seems to dissociate the NF-KB-IKB complex in 
vitro and in vivo (63). This observation correlates well 
with recent work demonstrating that Raf-1, which also 
regulates  AP-1,  is required by T cells to induce  IL-2  pro- 
duction (64). Thus,  Raf-1  also may be a good candidate for 
regulation via Ly-6A/E, given the ability of anti-Ly-6NE 
to induce NF-KB and AP-1. A second pathway leading to 
nuclear NF-KB induction  was  described recently (31,  65), 
inasmuch as the p105 precursor of the  p50 NF-KB subunit 
has an  IKB-like function  for  p65 NF-KB (RelA) subunits. 
This latent p65-pl05 form of NF-KB is activated by 
proteolytic  processing of the p105 precursor, yielding an 
active ~ 6 5 ~ 5 0  NF-KB that can be translocated into the 
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nucleus. It is likely that activation of a specific protease for 
p105  is  dependent on its modification as a result of signal 
transduction.  EL4J(Ly-6).A4  cells  contained high levels of 
a  latent  cytoplasmic  precursor of NF-KB, which was acti- 
vated in vitro by deoxycholate treatment that released 
NF-KB  from  IKB (data not shown).  However, we have not 
as yet determined how T  cell  signaling affects cytoplasmic 
NF-KB and have not ruled out  proteolytic  processing as a 
potential  mechanism of activation. 
I t  is unlikely that  blockade of IL-2 production via  Ly- 
6A/E is analogous to T  cell  anergy.  T  cell  anergy  requires 
engagement of the TCR without any costimulatory signals, 
whereas Ly-6NE-mediated inhibition of IL-2 production 
is the result of costimulation through the TCR and Ly- 
6A/E. Nevertheless, there is  a  similarity in distal signaling 
events  for these two  processes,  because there is a  selective 
inhibitory effect on factors that control  IL-2 transcription. 
In two  recent reports, the molecular mechanism of T  cell 
anergy was studied; in one case, NF-KB and NF-AT  were 
specifically inhibited (66) and, in the other, AP-1 was pri- 
marily down-regulated (67). 
Targets for  NF-KB include  several  cytokines and recep- 
tor genes, such as IL-2, IL-6, IL-8, TNF-a, granulocyte 
macrophage  CSF, the IL-2R a-chain,  MHC class  I, and the 
MHC class 11-associated invariant chain (53, 60). Inas- 
much as  NF-KB is  a transcriptional regulator for a number 
of immunologically important genes, it is possible that 
triggering  Ly-6, which regulates NF-KB, might affect the 
expression of many other  genes in addition to IL-2; how- 
ever, we have not as yet systematically  examined  this is- 
sue.  Although the physiologic role of Ly-6A/E in vivo is 
still uncertain, engagement of these molecules  might rep- 
resent a mechanism to limit an ongoing  immune  response. 
The question of the  origin of Ly-6NE-mediated nega- 
tive signals  for TCR signaling  is now under investigation. 
The inhibition by CAMP of Ras-dependent activation of 
Raf (68) and the determination of NF-KB  as a main target 
of CAMP-dependent inhibition of IL-2 transcription (69) 
may suggest  a  linkage of Ly-6m-generated negative sig- 
nals  with the CAMP-dependent signal  pathway. 
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